Final hours! Save up to 50% OFF InvestingProCLAIM SALE

What you need to know about the coronavirus right now

Published 2020-11-11, 06:37 a/m

Nov 11 (Reuters) - Here's what you need to know about the coronavirus right now:

Russia says its vaccine is 92% effective

Russia's Sputnik V vaccine is 92% effective at protecting people from COVID-19 according to interim trial results, the country's sovereign wealth fund said on Wednesday, as Moscow rushes to keep pace with Western drugmakers in the race for a shot.

The initial results are only the second to be published from a late-stage human trial in the global effort to produce vaccines.

The results are based on data from the first 16,000 trial participants to receive both shots of the two-dose vaccine. Midwest states clamp down again

California and several states across the U.S. Midwest tightened restrictions on residents on Tuesday as the nation's top infectious disease specialist called on Americans to remain vigilant until a vaccine can be approved and distributed.

The new clampdowns were announced as the number of COVID-19 infections surged again in the United States with the onset of colder weather, straining hospitals and medical resources in some cities.

"There's a real thing called COVID-19 fatigue, that's understandable," Dr. Anthony Fauci, a member of the White House coronavirus task force, told CNN in an interview. "But hang in there a bit longer, do the things you need to do and we'll be OK." scolds provinces

Canadian Prime Minister Justin Trudeau on Tuesday urged premiers of the country's 10 provinces to "do the right thing" and take stricter measures to fight a rapidly spreading second wave of the coronavirus.

Over the past week Canada has posted a daily average of more than 3,800 cases.

The central province of Manitoba announced a major shutdown beginning on Thursday. All social gatherings will be forbidden, restaurants closed except for takeout meals, and recreational facilities shut. ready to roll out vaccine once regulator gives all-clear

Britain is ready to roll out tens of millions of COVID-19 vaccines to the public with care-home residents and the elderly first in line for a jab that medics hope will allow the world to return to some semblance of normality.

England's Deputy Chief Medical Officer Jonathan Van-Tam said the country was ready to roll out a vaccine once regulators approved it as safe, quipping that he had told his 78-year-old mother to be ready for a jab.

"Do I think we will then move at pace to keep up with the volumes that are supplied to us? Yes I absolutely do," Van-Tam told reporters. kills 15,000 U.S. mink

More than 15,000 mink in the United States have died of the coronavirus since August, and authorities are keeping about a dozen farms under quarantine while they investigate the cases, state agriculture officials said.

Global health officials are eying the animals as a potential risk for people after Denmark last week embarked on a plan to eliminate all of its 17 million mink, saying a mutated coronavirus strain could move to humans and evade future COVID-19 vaccines.

Latest comments

Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2024 - Fusion Media Limited. All Rights Reserved.